Laura E. Johnson
- Molecular Medicine top 2%
- Immunology top 5%
- Immunotherapy and Immune Responses 29
- T-cell and B-cell Immunology 5
- Endocrinology top 5%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 12
-
- Prostate Cancer Treatment and Research 10
-
- vaccines and immunoinformatics approaches 9
- RNA Interference and Gene Delivery 5
-
- Clostridium difficile and Clostridium perfringens research 6
-
- Cancer Research and Treatments 5
- Co-authors
- Douglas G. McNeelHector F. DeLucaThomas FryeJens C. EickhoffGlenn LiuBrian M. OlsonEdward J. DunphyAmeet Hingwe
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Immunology Immunotherapy (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Laura E. Johnson
65 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 110
- Molecular Medicine 286
- Applied Microbiology and Biotechnology 97
- Immunology 756
- Endocrinology 96
- Oncology 483
Countries citing papers authored by Laura E. Johnson
This map shows the geographic impact of Laura E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Johnson more than expected).
Fields of papers citing papers by Laura E. Johnson
This network shows the impact of papers produced by Laura E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Johnson. The network helps show where Laura E. Johnson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura E. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 29 | |
| 5 | 2021 | 2 | |
| 6 | 2018 | 2 | |
| 7 | 2017 | 11 | |
| 8 | 2016 | 2 | |
| 9 | 2014 | 48 | |
| 10 | 2014 | 43 | |
| 11 | 2013 | 29 | |
| 12 | 2012 | 242 | |
| 13 | 2012 | 11 | |
| 14 | 2012 | 26 | |
| 15 | 2010 | 4 | |
| 16 | 2010 | 16 | |
| 17 | Immunization of Lewis rats with a prostate cancer xenoantigen elicits predominantly xenoantigen epitope-specific T cell responses | 2006 | 1 |
| 18 | 2006 | 46 | |
| 19 | DNA vaccine encoding a prostate-specific protein elicits CD8 T cell immunity and tissue-specific inflammation | 2004 | 2 |
| 20 | 2002 | 37 |
About Laura E. Johnson
Laura E. Johnson is a scholar working on Immunology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 68 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (29 papers), Cancer Immunotherapy and Biomarkers (12 papers), Prostate Cancer Treatment and Research (10 papers), vaccines and immunoinformatics approaches (9 papers), Clostridium difficile and Clostridium perfringens research (6 papers), RNA Interference and Gene Delivery (5 papers), Cancer Research and Treatments (5 papers) and T-cell and B-cell Immunology (5 papers). The work is most often cited by research in Molecular Medicine (286 citations), Applied Microbiology and Biotechnology (97 citations) and Immunology (756 citations). Laura E. Johnson has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Douglas G. McNeel, Hector F. DeLuca, Thomas Frye, Jens C. Eickhoff, Glenn Liu, Brian M. Olson, Edward J. Dunphy, Ameet Hingwe, David L. Paterson and Mary Jane Staab. Their work appears in journals such as Journal of Clinical Oncology, Cancer Immunology Immunotherapy, Journal for ImmunoTherapy of Cancer, Clinical Infectious Diseases and American Journal of Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.